|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.97 CNY | +0.02% |
|
+2.61% | -3.09% |
| 06:36am | Gan & Lee Pharmaceuticals Gets Nod to Trial GLR1062 Injection | MT |
| 04-15 | Gan & Lee Pharmaceuticals' Subsidiary Doses First Subject for Phase III of GZR33 Injection Trial; Shares Up 3% | MT |
Executive Committee: Gan & Lee Pharmaceuticals.
| Manager | Positions heldSince | ||
|---|---|---|---|
![Wei Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>) Wei Chen 46 year |
| ||
Rong Zou 43 year |
|
Composition of the Board of Directors: Gan & Lee Pharmaceuticals.
| Director | CommitteesSince | ||||||
|---|---|---|---|---|---|---|---|
Wei Chen 46 year |
| ||||||
Guo Jun Zheng 58 year |
| ||||||
Zeng Yi Chang 61 year |
| ||||||
Yan Qing He 41 year |
| ||||||
Wei Qiang Song 44 year |
| ||||||
Kai Du 49 year |
| ||||||
Yi Wang 36 year |
| ||||||
Jiao Jiao 38 year |
| ||||||
Lei Yin 47 year |
| ||||||
Jia Xin Wang 33 year |
| ||||||
Zhong Ru Gan 78 year |
|
Latest Appointments: Gan & Lee Pharmaceuticals.
Former Officers and Directors: Gan & Lee Pharmaceuticals.
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
|
Age distribution of managers
Parity Men Women
| Male | 9 |
|---|---|
| Female | 3 |
Of which Executive Committee
| Male | 1 |
|---|---|
| Female | 1 |
Of which Directors
| Male | 9 |
|---|---|
| Female | 2 |
Departures of Key Persons
Chairman
09/09/2021 -
Chairman
25/04/2019 -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition